Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Lipid-altering effects of different formulations of hydroxypropylmethylcellulose.

Maki KC, Carson ML, Kerr Anderson WH, Geohas J, Reeves MS, Farmer MV, Turowski M, Miller M, Kaden VN, Dicklin MR, Rains TM.

J Clin Lipidol. 2009 May-Jun;3(3):159-66. doi: 10.1016/j.jacl.2009.04.053. Epub 2009 May 5.

PMID:
21291811
2.

Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia.

Maki KC, Carson ML, Miller MP, Anderson WH, Turowski M, Reeves MS, Kaden V, Dicklin MR.

Eur J Clin Nutr. 2009 Aug;63(8):1001-7. doi: 10.1038/ejcn.2009.9. Epub 2009 Feb 11.

PMID:
19209184
3.

Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose.

Maki KC, Davidson MH, Malik KC, Albrecht HH, O'Mullane J, Daggy BP.

Am J Cardiol. 1999 Nov 15;84(10):1198-203.

PMID:
10569330
4.

High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men.

Maki KC, Davidson MH, Torri S, Ingram KA, O'Mullane J, Daggy BP, Albrecht HH.

J Nutr. 2000 Jul;130(7):1705-10.

6.

Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels.

Polagruto JA, Wang-Polagruto JF, Braun MM, Lee L, Kwik-Uribe C, Keen CL.

J Am Diet Assoc. 2006 Nov;106(11):1804-13.

PMID:
17081832
7.
10.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group..

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
11.

A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O; 3T Study Investigators..

Clin Ther. 2003 Jan;25(1):119-38.

PMID:
12637115
12.
13.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
15.

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group..

Am Heart J. 2004 Sep;148(3):447-55.

PMID:
15389231
16.

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.

Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT.

Clin Ther. 2001 Feb;23(2):177-92.

PMID:
11293552
17.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group..

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
18.
19.
20.

Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.

Maki KC, Beiseigel JM, Jonnalagadda SS, Gugger CK, Reeves MS, Farmer MV, Kaden VN, Rains TM.

J Am Diet Assoc. 2010 Feb;110(2):205-14. doi: 10.1016/j.jada.2009.10.037.

PMID:
20102847

Supplemental Content

Support Center